ORTX Insider Trading

29.90% of Orchard Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Orchard Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/15/2024	Beryl Capital Management LLC	1,561,499	$25.69M	13.6%	N/A	6.861%
2/14/2024	ADAR1 Capital Management LLC	63,622	$1.05M	0.4%	N/A	0.280%
2/14/2024	PenderFund Capital Management Ltd.	23,580	$0.39M	0.0%	N/A	0.104%
2/14/2024	Harvest Management LLC	10,000	$0.16M	0.2%	N/A	0.044%
2/14/2024	Water Island Capital LLC	91,000	$1.50M	0.2%	N/A	0.400%
2/13/2024	GABELLI & Co INVESTMENT ADVISERS INC.	192,650	$3.17M	0.6%	N/A	0.846%
2/13/2024	Gabelli Funds LLC	224,250	$3.69M	0.0%	N/A	0.985%
2/13/2024	Carmignac Gestion	39,468	$0.65M	0.0%	N/A	0.173%
2/6/2024	BCK Capital Management LP	43,642	$0.72M	0.7%	N/A	0.192%
1/12/2024	FNY Investment Advisers LLC	15,000	$0.25M	0.3%	N/A	0.066%
11/13/2023	CHI Advisors LLC	12,315,654	$95.20M	28.5%	+1,529.6%	54.199%
11/13/2023	Federated Hermes Inc.	869,327	$6.72M	0.0%	+71.1%	3.826%
11/13/2023	Mariner LLC	192,250	$1.49M	0.0%	+24.5%	0.846%
11/8/2023	Banque Cantonale Vaudoise	10,400	$81K	0.0%	+333.3%	0.046%
11/8/2023	Forefront Analytics LLC	14,183	$0.11M	0.1%	N/A	0.062%
8/22/2023	CHI Advisors LLC	755,738	$3.94M	1.2%	-3.8%	3.326%
8/14/2023	Deep Track Capital LP	2,041,670	$10.64M	0.5%	+75.0%	8.986%
8/14/2023	Temasek Holdings Private Ltd	352,379	$1.84M	0.0%	-18.4%	1.912%
8/11/2023	Platinum Investment Management Ltd.	248,462	$1.29M	0.0%	+108.6%	1.348%
5/15/2023	Temasek Holdings Private Ltd	431,904	$2.32M	0.0%	-90.0%	2.348%
5/12/2023	Forefront Analytics LLC	14,654	$79K	0.0%	-91.1%	0.080%
5/12/2023	Platinum Investment Management Ltd.	119,128	$0.64M	0.0%	N/A	0.648%
5/11/2023	Acadian Asset Management LLC	120,259	$0.65M	0.0%	-90.0%	0.654%
5/11/2023	CHI Advisors LLC	785,738	$4.22M	1.1%	-90.2%	4.271%
5/8/2023	Federated Hermes Inc.	1,925,377	$10.34M	0.0%	-77.1%	10.464%
4/7/2023	Sanders Morris Harris LLC	10,250	$55K	0.0%	N/A	0.056%
2/13/2023	Forefront Analytics LLC	164,894	$61K	0.0%	+64.8%	0.130%
11/15/2022	Federated Hermes Inc.	8,401,687	$4.20M	0.0%	+1.1%	6.644%
11/14/2022	UBS Oconnor LLC	432,978	$0.22M	0.0%	-60.4%	0.342%
11/10/2022	Strategic Wealth Advisors Group LLC	516,975	$0.26M	0.0%	N/A	0.409%
8/12/2022	Artisan Partners Limited Partnership	3,322,737	$1.94M	0.0%	-37.8%	2.628%
5/11/2022	GSA Capital Partners LLP	374,276	$0.27M	0.0%	+10.5%	0.297%
5/9/2022	Forefront Analytics LLC	99,741	$72K	0.0%	+89.7%	0.079%
5/5/2022	New York State Common Retirement Fund	323,397	$0.23M	0.0%	-66.2%	0.257%
4/29/2022	SG Americas Securities LLC	1,052,786	$0.75M	0.0%	+62.0%	0.837%
4/28/2022	Harbor Capital Advisors Inc.	236,681	$0.17M	0.1%	-14.2%	0.188%
2/14/2022	Eversept Partners LP	419,581	$0.55M	0.0%	-26.3%	0.334%
2/14/2022	GSA Capital Partners LLP	338,756	$0.45M	0.1%	-9.6%	0.270%
2/10/2022	Acadian Asset Management LLC	108,165	$0.14M	0.0%	N/A	0.086%
2/7/2022	SG Americas Securities LLC	649,670	$0.86M	0.0%	N/A	0.518%
2/4/2022	Harbor Capital Advisors Inc.	275,870	$0.36M	0.1%	N/A	0.220%
2/2/2022	New York State Common Retirement Fund	956,258	$1.26M	0.0%	-26.7%	0.762%
11/16/2021	Squarepoint Ops LLC	33,030	$76K	0.0%	+65.2%	0.026%
11/16/2021	Casdin Capital LLC	2,575,000	$5.92M	0.1%	-19.9%	2.054%
11/15/2021	Marshall Wace LLP	157,194	$0.36M	0.0%	N/A	0.125%
11/15/2021	RA Capital Management L.P.	11,028,722	$25.37M	0.4%	-10.4%	8.797%
11/15/2021	Farallon Capital Management LLC	665,200	$1.53M	0.0%	-79.3%	0.531%
11/15/2021	Eversept Partners LP	569,581	$1.31M	0.1%	N/A	0.454%
11/15/2021	GSA Capital Partners LLP	374,811	$0.86M	0.1%	N/A	0.299%
11/12/2021	Renaissance Technologies LLC	1,064,379	$2.45M	0.0%	+964.4%	0.849%
11/12/2021	Jump Financial LLC	68,000	$0.16M	0.0%	+20.5%	0.054%
11/12/2021	Hennion & Walsh Asset Management Inc.	183,346	$0.42M	0.0%	-4.7%	0.146%
11/12/2021	Artisan Partners Limited Partnership	10,846,420	$24.95M	0.0%	-19.3%	8.651%
11/10/2021	Citigroup Inc.	142,755	$0.33M	0.0%	+20.5%	0.114%
11/10/2021	Rafferty Asset Management LLC	652,007	$1.50M	0.0%	-9.5%	0.520%
11/9/2021	BlackRock Inc.	652,833	$1.50M	0.0%	-3.4%	0.521%
11/9/2021	Platinum Investment Management Ltd.	1,078,315	$2.48M	0.1%	+43.4%	0.860%
11/5/2021	Daiwa Securities Group Inc.	13,257	$30K	0.0%	+9,867.7%	0.011%
8/18/2021	Ikarian Capital LLC	150,000	$0.66M	0.1%	-40.0%	0.120%
8/17/2021	Itau Unibanco Holding S.A.	7,825	$34K	0.0%	N/A	0.006%
8/17/2021	Price T Rowe Associates Inc. MD	1,342,858	$5.90M	0.0%	-0.5%	1.071%
8/17/2021	Boothbay Fund Management LLC	46,874	$0.21M	0.0%	-11.7%	0.037%
8/16/2021	Squarepoint Ops LLC	19,998	$88K	0.0%	-70.8%	0.016%
8/16/2021	State Street Corp	102,832	$0.45M	0.0%	-51.2%	0.082%
8/16/2021	Goldman Sachs Group Inc.	27,805	$0.12M	0.0%	+21.2%	0.022%
8/13/2021	Renaissance Technologies LLC	100,000	$0.44M	0.0%	N/A	0.080%
8/13/2021	Northern Trust Corp	26,049	$0.11M	0.0%	-41.0%	0.021%
8/13/2021	Jump Financial LLC	56,454	$0.25M	0.0%	N/A	0.045%
8/13/2021	QS Investors LLC	108,000	$0.48M	0.0%	+730.8%	0.086%
8/13/2021	Qube Research & Technologies Ltd	94,492	$0.42M	0.0%	N/A	0.075%
8/13/2021	Vident Investment Advisory LLC	43,810	$0.19M	0.0%	N/A	0.035%
8/13/2021	IPG Investment Advisors LLC	14,100	$62K	0.0%	N/A	0.011%
8/13/2021	ProShare Advisors LLC	12,007	$53K	0.0%	N/A	0.010%
8/12/2021	Legal & General Group Plc	50,510	$0.22M	0.0%	-20.9%	0.040%
8/12/2021	JPMorgan Chase & Co.	4,837,859	$21.24M	0.0%	+4.4%	3.859%
8/12/2021	Artisan Partners Limited Partnership	13,443,032	$59.02M	0.1%	+26.3%	10.723%
8/11/2021	CHI Advisors LLC	4,081,972	$17.92M	4.2%	+0.7%	3.256%
8/11/2021	BlackRock Inc.	675,716	$2.97M	0.0%	+28.1%	0.539%
8/11/2021	Lord Abbett & CO. LLC	1,626,603	$7.14M	0.0%	-8.1%	1.297%
8/11/2021	Banque Cantonale Vaudoise	16,500	$73K	0.0%	+57.1%	0.013%
8/10/2021	Virtus ETF Advisers LLC	44,471	$0.20M	0.1%	-32.6%	0.035%
8/10/2021	Citigroup Inc.	118,483	$0.52M	0.0%	+234.7%	0.095%
8/10/2021	Rafferty Asset Management LLC	720,818	$3.16M	0.0%	+8.1%	0.575%
8/6/2021	Mutual of America Capital Management LLC	236,817	$1.04M	0.0%	-4.1%	0.191%
8/6/2021	Sei Investments Co.	195,545	$0.86M	0.0%	+71.7%	0.158%
8/6/2021	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	55,626	$0.24M	0.0%	-32.5%	0.045%
8/5/2021	Fox Run Management L.L.C.	10,247	$45K	0.0%	N/A	0.008%
8/3/2021	Victory Capital Management Inc.	77,236	$0.34M	0.0%	-4.7%	0.062%
8/2/2021	Chicago Partners Investment Group LLC	17,678	$52K	0.0%	N/A	0.014%
5/19/2021	Copernicus Capital Management LLC	15,000	$0.11M	1.8%	N/A	0.012%
5/19/2021	Squarepoint Ops LLC	68,472	$0.50M	0.0%	-15.7%	0.057%
5/18/2021	Baker BROS. Advisors LP	734,431	$5.33M	0.0%	+120.9%	0.609%
5/18/2021	Millennium Management LLC	303,524	$2.20M	0.0%	+103.5%	0.252%
5/17/2021	Woodline Partners LP	56,297	$0.41M	0.0%	-92.3%	0.047%
5/17/2021	Ameriprise Financial Inc.	67,701	$0.49M	0.0%	-15.7%	0.056%
5/17/2021	Hennion & Walsh Asset Management Inc.	185,220	$1.35M	0.1%	N/A	0.154%
5/17/2021	HRT Financial LP	23,161	$0.17M	0.0%	N/A	0.019%
5/17/2021	Sphera Funds Management LTD.	1,366,564	$9.92M	0.8%	N/A	1.134%
5/17/2021	Ikarian Capital LLC	250,000	$1.82M	0.1%	N/A	0.207%
5/17/2021	Goldman Sachs Group Inc.	22,943	$0.17M	0.0%	-92.1%	0.019%

Data available starting January 2016

Orchard Therapeutics plc, a gene therapy company, research, develops, and commercialize hematopoietic stem cell and gene therapies in the United Kingdom, Italy, France, and Germany. It offers OTL-200, an ex vivo autologous hematopoietic stem cell gene therapy for the treatment of patients with metachromatic leukodystrophy under the Libmeldy brand; and Strimvelis, a gammaretroviral vector-based gene therapy for the treatment of adenosine deaminase deficiency. The company's program for neurodegenerative disorders comprises clinical proof of concept-stage program, which includes OTL-203 for the treatment of mucopolysaccharidosis type I and OTL-201 for mucopolysaccharidosis type IIIA, or MPS-IIIA; and pre-clinical program, OTL-204 for the treatment of frontotemporal dementia with progranulin mutations. In addition, it develops program for immunological disorders consist of pre-clinical programs, which includes OTL-104 for Crohn's disease with mutations in the nucleotide-binding oligomerization domain-containing protein 2; and OTL-105 for the treatment of hereditary angioedema. The company was formerly known as Orchard Rx Limited. Orchard Therapeutics plc was founded in 2015 and is headquartered in London, the United Kingdom. As of January 24, 2024, Orchard Therapeutics plc operates as a subsidiary of Kyowa Kirin Co., Ltd..

Today's Range

Now: $16.70

$16.70

50 Day Range

MA: $16.59

$16.40

$16.70

52 Week Range

Now: $16.70

$4.24

$16.72

Volume

N/A

Average Volume

157,287 shs

Market Capitalization

$380.09 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.55

Better than Bitcoin? The Biotech Stock with 46,751% Potential

From Behind the Markets | Ad

4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.

Get the name of the stock here >>>